These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 16055146

  • 1. Nucleofection of non-B cells with mini-Epstein-Barr virus DNA.
    Radons J, Gross C, Stangl S, Multhoff G.
    J Immunol Methods; 2005 Aug; 303(1-2):135-41. PubMed ID: 16055146
    [Abstract] [Full Text] [Related]

  • 2. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
    Krause SW, Gastpar R, Andreesen R, Gross C, Ullrich H, Thonigs G, Pfister K, Multhoff G.
    Clin Cancer Res; 2004 Jun 01; 10(11):3699-707. PubMed ID: 15173076
    [Abstract] [Full Text] [Related]

  • 3. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.
    Gross C, Hansch D, Gastpar R, Multhoff G.
    Biol Chem; 2003 Feb 01; 384(2):267-79. PubMed ID: 12675520
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunopurification of functional Asp-ase (natural killer cell granzyme B) using a monoclonal antibody.
    Trapani JA, Browne KA, Dawson M, Smyth MJ.
    Biochem Biophys Res Commun; 1993 Sep 15; 195(2):910-20. PubMed ID: 8373425
    [Abstract] [Full Text] [Related]

  • 6. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS.
    Exp Hematol; 2009 Oct 15; 37(10):1216-29. PubMed ID: 19638292
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.
    Moser C, Schmidbauer C, Gürtler U, Gross C, Gehrmann M, Thonigs G, Pfister K, Multhoff G.
    Cell Stress Chaperones; 2002 Oct 15; 7(4):365-73. PubMed ID: 12653481
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A, Ito Y, Akatsuka Y, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K.
    Eur J Immunol; 2006 Mar 15; 36(3):593-602. PubMed ID: 16479544
    [Abstract] [Full Text] [Related]

  • 10. Improved gene expression pattern using Epstein-Barr virus (EBV)-based plasmid and cationic emulsion.
    Min KA, Lee SK, Kim CK.
    Biomaterials; 2005 Mar 15; 26(9):1063-70. PubMed ID: 15369695
    [Abstract] [Full Text] [Related]

  • 11. Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs.
    Gehrmann M, Brunner M, Pfister K, Reichle A, Kremmer E, Multhoff G.
    Clin Cancer Res; 2004 May 15; 10(10):3354-64. PubMed ID: 15161689
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
    Tung CL, Hsieh PP, Chang JH, Chen RS, Chen YJ, Wang JS.
    Hum Pathol; 2008 Jul 15; 39(7):1018-25. PubMed ID: 18482744
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
    Bratke K, Kuepper M, Bade B, Virchow JC, Luttmann W.
    Eur J Immunol; 2005 Sep 15; 35(9):2608-16. PubMed ID: 16106370
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma.
    Schleypen JS, Baur N, Kammerer R, Nelson PJ, Rohrmann K, Gröne EF, Hohenfellner M, Haferkamp A, Pohla H, Schendel DJ, Falk CS, Noessner E.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):718-25. PubMed ID: 16467081
    [Abstract] [Full Text] [Related]

  • 16. Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells.
    Hromadnikova I, Li S, Kotlabova K, Dickinson AM.
    PLoS One; 2016 Feb 01; 11(3):e0151535. PubMed ID: 26982331
    [Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
    Suwiwat S, Pradutkanchana J, Ishida T, Mitarnun W.
    J Clin Virol; 2007 Dec 01; 40(4):277-83. PubMed ID: 17996493
    [Abstract] [Full Text] [Related]

  • 18. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T, Kobayashi H, Kishibe K, Takahara M, Ogino T, Ishii H, Oikawa K, Aoki N, Sato K, Kimura S, Shimizu N, Tateno M, Harabuchi Y.
    Clin Cancer Res; 2005 Dec 01; 11(23):8250-7. PubMed ID: 16322282
    [Abstract] [Full Text] [Related]

  • 19. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
    Jeon YK, Park CH, Kim KY, Li YC, Kim J, Kim YA, Paik JH, Park BK, Kim CW, Kim YN.
    J Pathol; 2007 Oct 01; 213(2):170-9. PubMed ID: 17768706
    [Abstract] [Full Text] [Related]

  • 20. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
    Imadome K, Shimizu N, Arai A, Miura O, Watanabe K, Nakamura H, Nonoyama S, Yamamoto K, Fujiwara S.
    J Infect Dis; 2005 Oct 15; 192(8):1340-8. PubMed ID: 16170750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.